Navigating venous thromboembolism risks in lung cancer patients
- PMID: 38567710
- PMCID: PMC11091773
- DOI: 10.1111/1759-7714.15290
Navigating venous thromboembolism risks in lung cancer patients
Comment on
-
A systematic review of risk prediction model of venous thromboembolism for patients with lung cancer.Thorac Cancer. 2024 Feb;15(4):277-285. doi: 10.1111/1759-7714.15219. Epub 2024 Jan 17. Thorac Cancer. 2024. PMID: 38233997 Free PMC article.
Similar articles
-
Venous and Lung Thromboembolism in the Context of Lung Cancer: Clinical Manifestations, Risk Factors and Prognosis.Acta Med Port. 2019 Oct 1;32(10):647-653. doi: 10.20344/amp.10260. Acta Med Port. 2019. PMID: 31625877
-
Predictors of Venous Thromboembolism and Early Mortality in Lung Cancer: Results from a Global Prospective Study (CANTARISK).Oncologist. 2018 Feb;23(2):247-255. doi: 10.1634/theoncologist.2017-0205. Epub 2017 Sep 26. Oncologist. 2018. PMID: 28951500 Free PMC article.
-
Are direct oral anticoagulants an economically attractive alternative to low molecular weight heparins in lung cancer associated venous thromboembolism management?J Thromb Thrombolysis. 2020 Oct;50(3):642-651. doi: 10.1007/s11239-020-02047-1. J Thromb Thrombolysis. 2020. PMID: 32020515
-
Risk of recurrent venous thromboembolism according to malignancy characteristics in patients with cancer-associated thrombosis: a systematic review of observational and intervention studies.Blood Coagul Fibrinolysis. 2011 Mar;22(2):86-91. doi: 10.1097/MBC.0b013e328341f030. Blood Coagul Fibrinolysis. 2011. PMID: 21245746
-
Do we need prophylactic anticoagulation in ambulatory patients with lung cancer? A review.Vasc Med. 2020 Jun;25(3):255-262. doi: 10.1177/1358863X19899160. Epub 2020 Mar 7. Vasc Med. 2020. PMID: 32146869 Review.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical